About FRIZ Biochem
FRIZ Biochem is a Healthcare company based in Neuried (Germany) founded in 2003. DNA-chip biosensors for SNP detection are developed. FRIZ Biochem has raised $3.27 million across 3 funding rounds from investors including European Union, EIC Fund and DRF Beteiligung. FRIZ Biochem offers products and services including CYCLE Dx, Lab direct qPCR kits, and FRIZ Chemicals. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Bacterial. Its legal entity is FRIZ Biochem GmbH.
Company details
FRIZ Biochem was founded in 2003 in Neuried, Germany, and focuses on biotechnology for in-vitro diagnostics. Oligonucleotides and dithiol phosphoramidite are produced, alongside DNA-chip biosensors that enable direct electrical read-out for single nucleotide polymorphism detection without target-DNA labeling. The CYCLE diagnostics platform integrates sample preparation, multiplexed real-time PCR amplification, and detection within a cartridge equipped with an IC-chip, achieving results in 30 minutes.
- Headquarters Neuried, Germany
- SectorsHealthcare
- Website frizbiochem.de
- Social LinkedIn
- Legal Name Friz Biochem Gmbh
- Total Equity Funding$3.27M (USD)
in 3 rounds
- Latest Funding Round$62.23K (USD), Grant
Nov 2014
- InvestorsEuropean Union
& 3 more
Products & Services of FRIZ Biochem
FRIZ Biochem offers a comprehensive portfolio of products and services, including CYCLE Dx, Lab direct qPCR kits, and FRIZ Chemicals.
Platform for lab-free, multi-parametric PCR point-of-care testing.
Kits for fast, sensitive qPCR analysis without multi-step protocols.
Custom oligonucleotides and nanoparticles for R&D applications.
Funding Insights of FRIZ Biochem
FRIZ Biochem has successfully raised a total of $3.27M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $62.23 thousand completed in November 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.27M
- Total Rounds 3
- Last Round Grant — $62,233
- First Round $3.27M
(Apr 2003)
- Investors Count 4
All 3 funding rounds of FRIZ Biochem with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2014 | $62,233 | Grant | – | – | |
| Sep 2014 | $65,646 | Grant | – | – | |
| Apr 2003 | $3.27M | Series B | – | – |
4 investors in total: 4 institutional.
Investors in FRIZ Biochem
FRIZ Biochem has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, EIC Fund and DRF Beteiligung.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Early & late stage life sciences focused VC firm funding companies in the US and Europe | global-life-science-ventures.com | Munich, Germany | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Investment firm specializing in real estate projects and financing services. | 1987 | drf-beteiligung.de | Grunwald, Germany |
Investor details for FRIZ Biochem
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of FRIZ Biochem
3 dated milestones of FRIZ Biochem across 11 years, from founding to its latest funding, stage changes and deals.
- Founded FRIZ Biochem is founded.
- Funding First funding round of $3.3M.
- Funding Latest funding round, Grant, of $62K.
Web traffic of FRIZ Biochem
The website of FRIZ Biochem (frizbiochem.de) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 24.4% vs previous month
Websites whose visitors overlap most with FRIZ Biochem. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| europepmc.org | 100% | #53,748 | View details | ||
| bio-m.org | 100% | 13.9K | #1,671,971 | View details | |
beregszaszi-debr.sulinet.hu | beregszaszi-debr.sulinet.hu | 64% | – | ||
eng.ucmerced.edu | eng.ucmerced.edu | 61% | – | ||
gradworks.umi.com | gradworks.umi.com | 60% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for FRIZ Biochem
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about FRIZ Biochem
FRIZ Biochem was founded in 2003.
FRIZ Biochem is headquartered in Neuried, Germany. It is registered at Neuried, Bavaria, Germany.
FRIZ Biochem is a funded company, having raised a total of $3.27M across 3 funding rounds to date. The company's 1st funding round was a Series B of $3.27M, raised on Apr 2003.
FRIZ Biochem was founded in 2003 in Neuried, Germany, and focuses on biotechnology for in-vitro diagnostics. Oligonucleotides and dithiol phosphoramidite are produced, alongside DNA-chip biosensors that enable direct electrical read-out for single nucleotide polymorphism detection without target-DNA labeling. The CYCLE diagnostics platform integrates sample preparation, multiplexed real-time PCR amplification, and detection within a cartridge equipped with an IC-chip, achieving results in 30 minutes.
FRIZ Biochem offers CYCLE Dx, Lab direct qPCR kits, and FRIZ Chemicals.
FRIZ Biochem has 4 investors. Key investors include European Union, EIC Fund, DRF Beteiligung, and Global Life Science Ventures.
FRIZ Biochem operates through Friz Biochem Gmbh.